logo

For the Inventor, By the Inventor

Arlington, VA, United States of America

Ganesh Rai Bantukallu

This inventor holds 5 USPTO granted patents. Top assignees: The UAB Research Foundation (The University of Alabama at Birmingham), The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Pennsylvania. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ganesh Rai Bantukallu. Retrieved from https://idiyas.com/inventor/ganesh-rai-bantukallu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:

goldMedal5 out of 641 
 
The UAB Research Foundation (The University of Alabama at Birmingham)
 patents
silverMedal5 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
bronzeMedal5 out of 2,659 
 
University of Pennsylvania
 patents
4. 5 out of 1,221 
 
Vanderbilt University
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12365653 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2025-07-22),
2. 11897845 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2024-02-13),
3. 11247971 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2022-02-15),
4. 10961200 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-30),
5. 10351532 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2019-07-16),

Title: Ganesh Rai Bantukallu: Innovator in Cancer Treatment

Introduction

Ganesh Rai Bantukallu is a prominent inventor based in Arlington, VA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of small molecule inhibitors.

Latest Patents

Ganesh Rai Bantukallu holds a total of 5 patents. His latest patents include small molecule inhibitors of lactate dehydrogenase, which are crucial in the treatment of cancer. These compounds are designed to inhibit lactate dehydrogenase A (LDHA) and lactate dehydrogenase B (LDHB) activity in cells. The methods of use for these compounds include treating cancer and addressing cases where cancer cells are resistant to anti-cancer agents.

Career Highlights

Throughout his career, Ganesh has worked with esteemed institutions such as Vanderbilt University and the UAB Research Foundation. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.

Collaborations

Ganesh has collaborated with notable colleagues, including David Joseph Maloney and Alex Gregory Waterson. These partnerships have further enhanced his research and development efforts in the field of cancer treatment.

Conclusion

Ganesh Rai Bantukallu is a dedicated inventor whose work in developing small molecule inhibitors has the potential to transform cancer treatment. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…